![Han-Gu Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 4 M $ al 30/06/2026
Han-Gu Lee worked as the Co-Chief Executive Officer & Director at DAE HWA PHARM Co., Ltd., HLB Pharmaceutical Co., Ltd., and RedoxBio Co., Ltd. He started his job at HLB Pharmaceutical Co., Ltd. in 2016 and ended it in 2017.
Dr. Lee received his undergraduate and doctorate degrees from Sungkyunkwan University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/12/2025 | 596.327 ( 3,2 % ) | 4 M $ | 30/06/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
RedoxBio Co., Ltd.
 RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells sodium hyaluronate | Director Ejecutivo | 31/05/2024 |
| HLB PHARMACEUTICAL CO., LTD. | Director Ejecutivo | 31/05/2017 |
| DAE HWA PHARMACEUTICAL CO., LTD. | Director Ejecutivo | 20/03/2015 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 4 |
|---|---|
DAE HWA PHARM Co., Ltd.
 DAE HWA PHARM Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sungkyunkwan University
 Sungkyunkwan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HLB Pharmaceutical Co., Ltd.
 HLB Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and related products based on biotechnology | Health Technology |
RedoxBio Co., Ltd.
RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells sodium hyaluronate | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
